Please complete the form here or contact [email protected] to learn more about licensing content from the Endocrine Society.

If you believe you should have access to this media, please login.

Defining Success or Failure in Osteoporosis Treatment

Session Description

All medications used for the treatment of osteoporosis have the potential to improve bone mineral density and reduce fracture risk. Despite such documented benefits, some patients who receive osteoporosis therapy will suffer a subsequent fracture. This session will focus on how to define success or failure of osteoporosis therapy in the individual patient, considering endpoints such as changes in bone mineral density, the absence or occurrence of a new fracture, and changes in biochemical markers of bone turnover.

Presentations in This Video

Defining Success or Failure in Osteoporosis Treatment

Matthew Drake, MD, PhD

Mayo Clinic

Defining Success or Failure in Osteoporosis Treatment

Ian Reid, MD, FRACP

University of Auckland, NZ

Related Media